Charles River Laboratories | CRL - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Agilent USD 408M 44M 2026-03
Align Technology USD 148.69M 193K 2026-06
Bio-Rad Laboratories USD 542.1M 1.23B 2026-06
Bruker USD 117M 95.1M 2026-06
Cardinal Health USD 782M 390M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Cigna USD 2.27B 453M 2026-03
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Elevance Health USD 2.16B 146M 2026-06
Humana USD 1.6B 2.61B 2026-03
Illumina USD 260M 103M 2026-06
Incyte USD 751.51M 407.91M 2026-06
Intrexon USD -60.48M 27.09M 2024-06
IQVIA Holdings USD 301M 5.92B 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Lonza CHF 624M 197M 2024-12
McKesson USD 2.12B 495M 2026-03
Merck EUR 869M 468M 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Quest Diagnostics USD 334M 4M 2026-03
Revvity USD 187.24M 137.25M 2026-06
Thermo Fisher Scientific USD 1.73B 389M 2026-03
United Therapeutics USD 372.7M 54.4M 2026-06
UnitedHealth USD 7.36B 600M 2026-06
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 356M 444M 2026-06
West Pharmaceutical Services USD 180.1M 18.6M 2026-03